Literature DB >> 11884229

Regulation of the immune response by SHIP.

Michael E March1, Kodi Ravichandran.   

Abstract

Multiple lines of experimental data indicate that SHIP1 is an important negative regulator of the immune system. SHIP1 has been demonstrated to control survival and proliferation, as well as differentiation. In the cases of some inhibitory receptors, such as Fc gamma RIIB1, the molecular mechanisms of control by SHIP1 are established. For other receptors, particularly activating receptors where SHIP1 appears to set activation thresholds, the mechanisms remain to be discovered. Further study on SHIP and other SHIP family members could be critical for our understanding the negative regulation in multiple hematopoietic lineages and the immune system as a whole. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11884229     DOI: 10.1006/smim.2001.0340

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  22 in total

1.  CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors.

Authors:  Katarzyna Kowanetz; Koraljka Husnjak; Daniela Höller; Marcin Kowanetz; Philippe Soubeyran; Dianne Hirsch; Mirko H H Schmidt; Kresimir Pavelic; Pietro De Camilli; Paul A Randazzo; Ivan Dikic
Journal:  Mol Biol Cell       Date:  2004-04-16       Impact factor: 4.138

2.  Inhibition of mast cell degranulation by a chimeric toxin containing a novel phosphatidylinositol-3,4,5-triphosphate phosphatase.

Authors:  Bruce J Shenker; Kathleen Boesze-Battaglia; Ali Zekavat; Lisa Walker; Dave Besack; Hydar Ali
Journal:  Mol Immunol       Date:  2010-09-21       Impact factor: 4.407

3.  C-reactive protein inhibits insulin activation of endothelial nitric oxide synthase via the immunoreceptor tyrosine-based inhibition motif of FcgammaRIIB and SHIP-1.

Authors:  Keiji Tanigaki; Chieko Mineo; Ivan S Yuhanna; Ken L Chambliss; Michael J Quon; Ezio Bonvini; Philip W Shaul
Journal:  Circ Res       Date:  2009-05-07       Impact factor: 17.367

4.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

5.  Lymphoid susceptibility to the Aggregatibacter actinomycetemcomitans cytolethal distending toxin is dependent upon baseline levels of the signaling lipid, phosphatidylinositol-3,4,5-triphosphate.

Authors:  B J Shenker; L P Walker; A Zekavat; K Boesze-Battaglia
Journal:  Mol Oral Microbiol       Date:  2015-09-24       Impact factor: 3.563

6.  A key role for the phosphorylation of Ser440 by the cyclic AMP-dependent protein kinase in regulating the activity of the Src homology 2 domain-containing Inositol 5'-phosphatase (SHIP1).

Authors:  Jun Zhang; Kodi S Ravichandran; James C Garrison
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

7.  The inhibitory potential of Fc receptor homolog 4 on memory B cells.

Authors:  Gotz R A Ehrhardt; Randall S Davis; Joyce T Hsu; Chuen-Miin Leu; Annette Ehrhardt; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-03       Impact factor: 11.205

8.  A physical interaction between the adaptor proteins DOK3 and DAP12 is required to inhibit lipopolysaccharide signaling in macrophages.

Authors:  Qisheng Peng; Courtney L Long; Shikha Malhotra; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2013-08-20       Impact factor: 8.192

9.  The inositol phosphatase SHIP controls Salmonella enterica serovar Typhimurium infection in vivo.

Authors:  Jennifer L Bishop; Laura M Sly; Gerald Krystal; B Brett Finlay
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

Review 10.  PIP3 pathway in regulatory T cells and autoimmunity.

Authors:  Masaki Kashiwada; Ping Lu; Paul B Rothman
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.